An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Several professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Content Elimination
Based on TikTok, the platform has taken down violative content and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.
After minutes of joining one community, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Details and Costs
Inside these communities, posts display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly significant medical dangers”.
